GL
EW icon

Graypoint LLC’s Edwards Lifesciences EW Stock Holding History

Graypoint LLC’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$387K Buy
4,954
+761
+18% +$56.8K 0.02% 380
2025
Q1 		$304K Buy
4,193
+862
+26% +$61.7K 0.02% 405
2024
Q4 		$247K Buy
+3,331
New +$233K 0.01% 447
2024
Q3 		– Sell
-4,217
Closed -$390K – 496
2024
Q2 		$390K Buy
4,217
+690
+20% +$61.1K 0.03% 337
2024
Q1 		$337K Buy
+3,527
New +$296K 0.02% 351
2023
Q3 		– Sell
-5,300
Closed -$500K – 413
2023
Q2 		$500K Buy
5,300
+1,101
+26% +$95.7K 0.05% 218
2023
Q1 		$347K Buy
+4,199
New +$330K 0.04% 262

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Graypoint LLC's EW Position: Q2 2025 in Review

Graypoint LLC increased its Edwards Lifesciences (EW) stake by 18% in Q2 2025, buying an estimated $56.8K and bringing the position to 4,954 shares worth $387K. The position accounts for 0.02% of the portfolio, ranked #380.

Graypoint LLC first reported a position in EW in Q1 2023 and has held it in 7 quarters since. The position peaked at $500K in Q2 2023. 1,259 funds tracked by Wall St. Rank hold EW as of Q2 2025.

  • Graypoint LLC held 4,954 shares of Edwards Lifesciences worth $387K as of Q2 2025.
  • Graypoint LLC bought 761 Edwards Lifesciences shares in Q2 2025, an estimated $56.8K.
  • Edwards Lifesciences made up 0.02% of Graypoint LLC's portfolio in Q2 2025, its #380 holding.
  • Graypoint LLC first reported a position in Edwards Lifesciences in Q1 2023 and has held it in 7 quarters since.
  • Graypoint LLC's Edwards Lifesciences position peaked at $500K in Q2 2023.
  • 1,259 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2025.

Based on Graypoint LLC's 13F filing for Q2 2025, filed 15 Jul 2025.